Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

被引：0
|
作者：
Brandon, Donald [1 ]
Kimmel, Murray [2 ]
Kuriyakose, Sherine O. [3 ]
Kostanyan, Lusine [4 ,5 ]
Mesaros, Narcisa [5 ]
机构：
[1] Calif Res Fdn, 4180 Ruffin Rd, San Diego, CA 92123 USA
[2] Accelovance Suite, Suite 102,1600 West Eau Gallie Blvd, Melbourne, FL USA
[3] GSK, 5 Embassy Links,Cunningham Rd, Bangalore 560052, Karnataka, India
[4] XPE Pharma & Sci, 19A Ave Edison, B-1300 Wavre, Belgium
[5] GSK, 20 Ave Fleming, B-1300 Wavre, Belgium
来源：
VACCINE | 2020年 / 38卷 / 12期
关键词：
D O I：
10.1016/j.vaccine.2020.01.082
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2746 / 2747
页数：2
相关论文
共 38 条
  • [31] Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines
    Vesikari, Timo
    Forsten, Aino
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (12) : E298 - E307
  • [32] Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018
    Haber, Penina
    Moro, Pedro L.
    Ng, Carmen
    Dores, Graca M.
    Perez-Vilar, Silvia
    Marquez, Paige L.
    Cano, Maria
    VACCINE, 2020, 38 (06) : 1476 - 1480
  • [33] A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK
    Marlow, Robin
    Kuriyakose, Sherine
    Mesaros, Narcisa
    Han, Htay Htay
    Tomlinson, Richard
    Faust, Saul N.
    Snape, Matthew D.
    Pollard, Andrew J.
    Finn, Adam
    VACCINE, 2018, 36 (17) : 2300 - 2306
  • [34] Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
    Tejedor, Juan Carlos
    Brzostek, Jerzy
    Konior, Ryszard
    Grunert, Detlef
    Kolhe, Devayani
    Baine, Yaela
    Van Der Wielen, Marie
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (07) : 555 - 563
  • [35] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12–23 months
    Fred Zepp
    Ulrich Behre
    Klaus Kindler
    Karl-Heinz Laakmann
    Heidemarie Pankow-Culot
    Wilma Mannhardt-Laakmann
    François Beckers
    Dominique Descamps
    Paul Willems
    European Journal of Pediatrics, 2007, 166 : 857 - 864
  • [36] Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine A randomized, controlled trial in children primed according to a 2+1 schedule in infancy
    Ferrera, Giuseppe
    Cuccia, Mario
    Mereu, Gabriele
    Icardi, Giancarlo
    Bona, Gianni
    Esposito, Susanna
    Marchetti, Federico
    Messier, Marc
    Kuriyakose, Sherine
    Hardt, Karin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (03)
  • [37] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
    Zepp, Fred
    Behre, Ulrich
    Kindler, Klaus
    Laakmann, Karl-Heinz
    Pankow-Culot, Heidemarie
    Mannhardt-Laakmann, Wilma
    Beckers, Francois
    Descamps, Dominique
    Willems, Paul
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (08) : 857 - 864
  • [38] Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older-Advisory Committee on Immunization Practices (ACIP), 2012 (Reprinted from MMWR, vol 61, pg 468-470, 2012)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (10): : 968 - 970
1234